With New Zealanders ready to request entry to medicinal cannabis dried flower for the first time ever as of immediately, one among Australia’s main personal medicinal cannabis corporations has acquired export approval from our Kiwi neighbours.
Byron Bay-based Australian Natural Therapeutics Group (ANTG) has been granted the inexperienced mild to ship its regionally cultivated product to New Zealand – the first Aussie company to accomplish that – in partnership with an area distributor of the drugs.
ANTG’s Eve CBD flower might be accessed by means of NZ’s largest medicinal cannabis distributor NUBU Pharmaceuticals in what the Australian company’s CEO Matthew Cantelo mentioned was a landmark deal for each nations.
“This agreement is not only a historic first for New Zealand, but also beneficial for the Australian industry as a whole,” Cantelo mentioned.
“The high benchmarks in Australia for growing and producing medicinal cannabis has set us up as the best in the world. We have a reputation and climate for growing excellent produce in general – it makes sense that we would produce the highest quality medicinal cannabis product as well.
“Our Kiwi neighbours will also have access to the highest quality Australian flower while their home-grown cultivation industry starts producing.”
NUBU Pharmaceuticals co-founder and CEO Mark Dye mentioned he couldn’t be happier about the deal, which is able to give New Zealanders entry to ANTG’s top quality medicinal cannabis merchandise.
“Being the first company to legally sell cannabis in New Zealand is beyond exciting – I can’t even begin to explain the blood, sweat and tears it has taken to get here,” Dye mentioned.
“I am excited for the patients – they have been calling out for this for decades. I am so proud it is the team at NUBU that has been able to make this happen for them.
“ANTG are very much leading the Australasian cannabis industry. We are over the moon to have them as a distribution partner.”